Success Metrics

Clinical Success Rate
66.7%

Based on 8 completed trials

Completion Rate
67%(8/12)
Active Trials
0(0%)
Results Posted
63%(5 trials)
Terminated
4(21%)

Phase Distribution

Ph phase_4
10
53%
Ph phase_2
2
11%
Ph phase_3
2
11%
Ph not_applicable
4
21%

Phase Distribution

0

Early Stage

2

Mid Stage

12

Late Stage

Phase Distribution18 total trials
Phase 2Efficacy & side effects
2(11.1%)
Phase 3Large-scale testing
2(11.1%)
Phase 4Post-market surveillance
10(55.6%)
N/ANon-phased studies
4(22.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

8 of 12 finished

Non-Completion Rate

33.3%

4 ended early

Currently Active

0

trials recruiting

Total Trials

19

all time

Status Distribution
Active(1)
Completed(8)
Terminated(4)
Other(6)

Detailed Status

Completed8
unknown6
Terminated4
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
19
Active
0
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (11.1%)
Phase 32 (11.1%)
Phase 410 (55.6%)
N/A4 (22.2%)

Trials by Status

terminated421%
completed842%
unknown632%
not_yet_recruiting15%

Recent Activity

Clinical Trials (19)

Showing 19 of 19 trials
NCT07270848Phase 4

Dronedarone Rhythm Intervention for Early Atrial Fibrillation

Not Yet Recruiting
NCT05130268Phase 4

Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation

Completed
NCT05279833

Systematic Review and Meta-Analysis of Multaq® for Safety in Atrial Fibrillation

Completed
NCT05655468Phase 4

Effect of Prolonged Use of Dronedarone on Recurrence in Patients With Non-paroxysmal Atrial Fibrillation After Radiofrequency Ablation

Unknown
NCT01522651Phase 2

Study to Evaluate the Effect of Ranolazine and Dronedarone When Given Alone and in Combination in Patients With Paroxysmal Atrial Fibrillation

Completed
NCT03905759Phase 2

Prophylaxis Against Postoperative Atrial Fibrillation in Patients Undergoing On-pump CABG

Unknown
NCT02294955Not Applicable

Catheter Ablation Compared With Pharmacological Therapy for Atrial Fibrillation (CAPTAF Trial)

Unknown
NCT01182376Phase 3

SOAR: Study Observing Antiarrhythmic Remodelling Using LGE-MRI

Completed
NCT01026090Phase 4

Dronedarone Pattern of Use in Patients Scheduled for Elective Cardioversion (ELECTRA)

Terminated
NCT01991119Not Applicable

Efficacy of Propafenone Versus Dronedarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation

Completed
NCT01199081Phase 4

Pharmacokinetics and Optimal Timing of Dronedarone Initiation Following Long-term Amiodarone in Patients With Paroxysmal or Persistent Atrial Fibrillation

Completed
NCT01135017Phase 4

Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent Pacemakers

Terminated
NCT01198873Phase 4

Effects of Dronedarone on Cardiac Geometry and Function in Patients With Atrial Fibrillation and Left Atrial Enlargement

Terminated
NCT01151137Phase 3

Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy

Terminated
NCT01140581Phase 4

Optimal Timing of Dronedarone Initiation After Conversion in Patients With Persistent Atrial Fibrillation

Completed
NCT01047566Phase 4

Effect of Addition of Dronedarone to Standard Rate Control Therapy on Ventricular Rate During Persistent Atrial Fibrillation (AFRODITE)

Completed
NCT01430806Not Applicable

Dronaderone to Prevent Recurrent Implantable Cardioverter Defibrillator (ICD) Shocks

Unknown
NCT01266681Not Applicable

Amiodarone Compared to Dronedarone , Post Cardioversion Maintenance of Sinus Rhythm

Unknown
NCT01070667Phase 4

Dronedarone in Pacemakers Patients With Paroxysmal Atrial Fibrillation

Unknown

All 19 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
19